Acute hemolytic anemia induced by oral administration of indole in ponies.
Eight ponies were allotted to 2 groups of 4. Group-1 ponies (1-4) were given 0.2 g of indole/kg of body weight orally and group-2 ponies (5 to 8) were given 0.1 g of indole/kg. Various physical, hematologic, and physiologic measurements were obtained after administration of indole. Intravascular hemolysis and hemoglobinuria were detected in both groups within 24 hours of dosing. Hemolysis was reflected by decreases in PCV, hemoglobin concentration, and RBC count, and an increase in indirect bilirubin. Erythrocyte fragility appeared to increase in both groups at 8 hours after dosing and peaked at 16 hours after dosing. At 72 hours after dosing, the RBC fragility value was less than predose measurements. Heinz body formation was noticed in group-2 ponies, but not in group 1. Plasma indole concentrations increased in both groups from the nondetectable predose concentrations. Group-1 values were 203% of group-2 values. In group 2, plasma indole was nondetectable by 12 hours, whereas low concentrations could still be measured in the group-1 ponies at 24 hours. Ponies in group 1 died or were euthanatized between 24 and 72 hours after dosing, whereas group-2 ponies were euthanatized between 48 and 120 hours. At necropsy, all body fat, mucous membranes, and elastic tissue were stained yellow. Hemoglobinuric nephrosis was the most prominent microscopic lesion. Results of this study indicated that indole, a metabolite of the amino acid tryptophan, causes acute intravascular hemolysis in ponies.
Paradis
M R
MR
Department of Medicine, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.
Breeze
R G
RG
Laegreid
W W
WW
Bayly
W M
WM
Counts
D F
DF
D000208:Acute Disease; D000284:Administration, Oral; D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D000818:Animals; D001663:Bilirubin / Q000097:blood; D004906:Erythrocyte Count / Q000187:drug effects / Q000662:veterinary; D005260:Female; D006400:Hematocrit / Q000662:veterinary; D006454:Hemoglobins / Q000032:analysis; D006456:Hemoglobinuria / Q000139:chemically induced / Q000662:veterinary; D006461:Hemolysis / Q000187:drug effects; D006734:Horse Diseases / Q000139:chemically induced* / Q000473:pathology; D006736:Horses; D007211:Indoles / Q000008:administration & dosage / Q000097:blood / Q000633:toxicity*; D007501:Iron / Q000097:blood; D008297:Male; D009994:Osmolar Concentration; D009996:Osmotic Fragility / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D006454:Hemoglobins; D007211:Indoles; C030374:indole; D007501:Iron; D001663:Bilirubin